Anemia of chronic disease: Past, present, and future (Q35553274)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531769%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Anemia of chronic disease: past, present, and future (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531769%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Anemia of chronic disease: Past, present, and future (English)

1 reference

Crossref

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

anemia of chronic disease

19 March 2024

main subject

1 reference

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

19 March 2024

Robert D. Toto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531769

19 March 2024

language of work or name

1 reference

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531769%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

http://www.kidney-international.org/article/S0085253815496383/pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531769

https://api.elsevier.com/content/article/PII:S0085253815496383?httpAccept=text/xml

19 March 2024

1 reference

Crossref

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

https://api.elsevier.com/content/article/PII:S0085253815496383?httpAccept=text/plain

19 March 2024

1 reference

Crossref

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Kidney International. Supplement

19 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531769%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531769%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

S20-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531769%20AND%20SRC:MED&resulttype=core&format=json

Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Outcome and risk factors for left ventricular disorders in chronic uraemia

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994)

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Genetic variation of the renin-angiotensin system and chronic kidney disease progression in black individuals in the atherosclerosis risk in communities study

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Trends in anemia at initiation of dialysis in the United States.

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Incidence of anaemia, and use of epoetin therapy in pre-dialysis patients: a prospective study in 403 patients

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Anaemia, cardiovascular disease and kidney disease: integrating new knowledge in 2002.

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Anaemia management in chronic kidney disease patients: an overview of current clinical practice

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Anemia during the predialysis period: A key to cardiac damage in renal failure

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

The prognostic importance of anemia in patients with heart failure

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Cardiovascular effects of recombinant human erythropoietin in predialysis patients

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Anaemia as a risk factor for the progression of chronic kidney disease

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Haematocrit and the risk of developing end-stage renal disease

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Erythropoietin therapy may retard progression in chronic renal transplant dysfunction

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Reversal of Anemia by Erythropoietin Therapy Retards the Progression of Chronic Renal Failure, Especially in Nondiabetic Patients

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. The US Recombinant Human Erythropoietin Predialysis Study Group

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Renal function in predialysis children with chronic renal failure treated with erythropoietin

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Effect of erythropoietin treatment on physical exercise capacity and on renal function in predialytic uremic patients

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Treatment of the anemia of progressive renal failure with recombinant human erythropoietin

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Hypoxia of the renal medulla--its implications for disease

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Hypoxia promotes fibrogenesis in human renal fibroblasts

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.4.X

19 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531769%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531769%20AND%20SRC:MED&resulttype=core&format=json